Federal Employees Not Eligible for Social Security Benefits: United States Court of Appeals

Published Date: 16 Feb 2023

A divided U.S. appeals court ruled on Tuesday that federal workers generally do not deserve extra pay for being exposed to the COVID-19 virus on the job.

Read Full News

Latest News

WHO Global Alliance Delivers 100 M Child Vaccines Since 2023

More than 100 million vaccine doses have been delivered to millions of children since ⁠2023 under a global drive to reverse pandemic-related declines in childhood immunisation.

US Military No Longer Required to Get Flu Vaccine, Hegseth Says

The Pentagon will no longer require members of the U.S. military to get the ⁠flu vaccine, Defense Secretary Pete Hegseth said on Tuesday.

The Long-COVID Crisis: No Cure, Little Attention

On International Long COVID Awareness Day, advocates warned that long COVID — affecting 400 million people — remains underrecognized by clinicians and underfunded.

Moderna Starts Late-stage Trial of Bird Flu Vaccine in US, UK

Moderna said on Tuesday it had started a late-stage study of its experimental bird flu vaccine ⁠in the U.S. and the UK, marking the first time a pandemic bird flu vaccine...

Long COVID May Persist as Diagnostic Gaps Remain

Long COVID reflects persistent biological dysfunction with multisystem involvement, while gaps in biomarkers and treatment continue to complicate diagnosis and clinical care.

US CDC Will Not Publish Report Showing COVID Vaccine Effectiveness

A report showing the efficacy of COVID-19 vaccines has been blocked from being published in the U.S. ⁠Centers for Disease Control and Prevention's flagship scientific...

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Latest News

More than 100 million vaccine doses have been delivered to millions of children since ⁠2023 under a global drive to reverse pandemic-related declines in childhood immunisation.

The Pentagon will no longer require members of the U.S. military to get the ⁠flu vaccine, Defense Secretary Pete Hegseth said on Tuesday.

On International Long COVID Awareness Day, advocates warned that long COVID — affecting 400 million people — remains underrecognized by clinicians and underfunded.

Moderna said on Tuesday it had started a late-stage study of its experimental bird flu vaccine ⁠in the U.S. and the UK, marking the first time a pandemic bird flu vaccine...

Long COVID reflects persistent biological dysfunction with multisystem involvement, while gaps in biomarkers and treatment continue to complicate diagnosis and clinical care.

A report showing the efficacy of COVID-19 vaccines has been blocked from being published in the U.S. ⁠Centers for Disease Control and Prevention's flagship scientific...

News All Time

US CDC Delays Publishing Report Showing COVID Vaccine Benefits, WaPo Reports

The acting director of ⁠the Centers for Disease Control ⁠and Prevention has delayed publication ⁠of a ‌CDC report showing the COVID-19 vaccine cut the likelihood of...

US FDA Approves Waters' At‑home Cervical Cancer Screening Kit

Lab equipment maker Waters said on Wednesday the U.S. Food and Drug ⁠Administration has cleared its at-home cervical cancer screening kit for use with an ⁠approved HPV test,...

On-Site Hepatitis C Care Boosts Treatment Uptake

On-site hepatitis C virus testing and treatment with peer support at opioid treatment programs boosts access to curative therapy and sharply increases treatment initiation.

Fungal Extract May Improve COVID Vaccine Response

Researchers report that fungal extracts may influence vaccine reactogenicity and antibody kinetics, with effects observed only in individuals without prior SARS-CoV-2 exposure.

Can Severe Infections Raise Your Dementia Risk?

Severe infections such as cystitis and bacterial infection of an unspecified site may raise the risk of developing dementia, even after accounting for other illnesses.

Exclusive-US Upends Global Supply Program for Malaria and HIV Amid Warnings of Gaps

The U.S. is upending the way it delivers medical supplies for diseases such as HIV and malaria to lower-income countries, according to seven sources and an internal email,...

African Ancestry Linked to Fewer TB Adverse Events

A 10% rise in African ancestry lowered odds of moderate TB drug reactions, while a 10% increase in European ancestry raised them — implications for surveillance.

Cervical Cancer Screening Update: Why Less Is More

Cervical cancer screening has evolved. Dr Neil Skolnik delivers an update on why we now wait until age 25 to start and how self-testing is changing the pelvic exam landscape.

Exclusive-Pfizer, BioNTech Halt US COVID Vaccine Study After Recruitment Struggles

Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too...

Low CD4 Count Tied to Cervical Cancer Risk in HIV Infection

A lower CD4 count is associated with a higher risk for cervical carcinoma in situ and cervical cancer in women with HIV infection.

Does HIV Status Affect Long COVID Manifestations?

Patients with HIV infection are at a higher risk of developing long COVID manifestations than those without HIV infection.

Is Integrase Inhibitor-Based HIV Therapy Safe in Pregnancy?

In utero exposure to integrase inhibitor-based antiretroviral regimens is not associated with adverse 1-year neurodevelopmental outcomes compared with exposure to other antiretroviral regimens.

Ryan White: The Safety Net We Cannot Afford to Shrink

Dr Daskalakis shares the important strides that HIV/AIDS care has made and how critical access to care can be for some patients.

Nigerian HIV Volunteers Went Door-to-Door Amid Aid Cuts

For several months last year, Josephine Angev walked the dusty village paths of Nigeria's Benue State to help people living with HIV stay on their life-saving medication.

Kennedy Allies Petition to Broaden US Vaccine Injury List

An anti-vaccine group aligned with U.S. Health Secretary Robert F. Kennedy Jr. is petitioning him to vastly broaden a federal list to include more than 300 injuries it says...

Kids Confirmed as Top Transmitters of RSV

New modeling data support targeted prevention efforts.

Recommended News For You

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

Error on the MGUS-Autoimmune Disease Association.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

What Comes After Cancer?

Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

Recommended Articles For You

What You Need to Know about Hairy Cell Leukemia: A Comprehensive Guide  

Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post 

Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer 

A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Top 10 questions about breast cancer answered

2.

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

3.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

4.

Immunotherapy after surgery is good for patients with advanced cancer

5.

Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC

1.

Cerebrospinal Fluid Metabolite Biomarkers in Central Nervous System Tumor Monitoring: A New Frontier

2.

Introduction To Immune Thrombocytopenic Purpura

3.

Demystifying the Mentzer Index: Understanding Its Importance in Inventory Management 

4.

The Ins and Outs of Glossectomy: What You Need to Know 

5.

What is Hemorrhagic Cystitis and How to Manage its Symptoms

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

2.

Efficient Management of First line ALK-rearranged NSCLC - Part V

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

4.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot